BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 9116731)

  • 1. [Prostatic urothelial location of a tumor of the bladder].
    Coulange C; Lechevallier E; de Fromont M
    Prog Urol; 1997 Feb; 7(1):128-31. PubMed ID: 9116731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
    Liedberg F; Chebil G; Månsson W
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance.
    Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM
    Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prostatic involvement by urothelial carcinoma in patients with bladder cancer and their implications in the clinical practice].
    Huguet J
    Actas Urol Esp; 2012 Oct; 36(9):545-53. PubMed ID: 22520044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
    Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
    Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic transitional cell carcinoma: pathologic features and clinical management.
    Shen SS; Lerner SP
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1155-62. PubMed ID: 18028024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of prostatic involvement by urothelial carcinoma in radical cystoprostatectomy for bladder cancer.
    Mazzucchelli R; Barbisan F; Santinelli A; Scarpelli M; Galosi AB; Lopez-Beltran A; Cheng L; Kirkali Z; Montironi R
    Urology; 2009 Aug; 74(2):385-90. PubMed ID: 19501882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urothelial carcinoma of the prostate.
    Goebbels R; Amberger L; Wernert N; Dhom G
    Appl Pathol; 1985; 3(4):242-54. PubMed ID: 3842265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of transitional cell carcinoma in the prostatic urethra and prostate in the cystoprostatectomy specimen. Incidence, characteristics and preoperative detection.
    Liedberg F; Anderson H; Bläckberg M; Chebil G; Davidsson T; Gudjonsson S; Jahnson S; Olsson H; Månsson W
    Scand J Urol Nephrol; 2007; 41(4):290-6. PubMed ID: 17763219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urothelial bladder carcinoma in situ involving the whole urinary tract. One case (author's transl)].
    Bellocq JP; Lassabe-Roth C; Viville C; Camey M; Batzenschlager A
    J Urol (Paris); 1982; 88(4):255-60. PubMed ID: 7202029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary on prostate and urothelial carcinoma in cystoprostatectomy specimens.
    Lotan Y
    J Urol; 2008 May; 179(5 Suppl):S33-4. PubMed ID: 18405746
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathologic assessment and clinical significance of prostatic involvement by transitional cell carcinoma and prostate cancer.
    Lerner SP; Shen S
    Urol Oncol; 2008; 26(5):481-5. PubMed ID: 18774459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transitional cell carcinoma involvement of the prostate].
    Bassi P; De Lisa A; Usai P; Pinto F; Sacco E
    Ann Urol (Paris); 2005 Nov; 39 Suppl 5():S113-9. PubMed ID: 16425728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
    Stein JP; Clark P; Miranda G; Cai J; Groshen S; Skinner DG
    J Urol; 2005 Apr; 173(4):1163-8. PubMed ID: 15758728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary high grade sarcoma of the specialised prostatic stroma: a case report with clinico-pathological considerations.
    Fraggetta F; Pepe P; Giunta ML; Aragona F
    Pathologica; 2008 Dec; 100(6):482-4. PubMed ID: 19475893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of patients undergoing radical cystoprostatectomy for bladder cancer with prostatic involvement on final pathology.
    Barocas DA; Patel SG; Chang SS; Clark PE; Smith JA; Cookson MS
    BJU Int; 2009 Oct; 104(8):1091-7. PubMed ID: 19389006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we identify those patients who will benefit from prostate-sparing surgery? Predictive factors for invasive prostatic involvement by transitional cell carcinoma.
    Arce J; Gaya JM; Huguet J; Rodriguez O; Palou J; Villavicencio H
    Can J Urol; 2011 Feb; 18(1):5529-36. PubMed ID: 21333045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant pathology in the prostate in cystoprostatectomy specimens: a prospective study and review.
    Saad M; Abdel-Rahim M; Abol-Enein H; Ghoneim MA
    BJU Int; 2008 Dec; 102(11):1544-50. PubMed ID: 18565169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder.
    Moutzouris G; Barbatis C; Plastiras D; Mertziotis N; Katsifotis C; Presvelos V; Theodorou C
    Scand J Urol Nephrol; 1999 Feb; 33(1):27-30. PubMed ID: 10100360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.